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Abstract
The collaborative cross (CC) is a large panel of mouse-inbred lines derived from eight founder strains (NOD/ShiLtJ, NZO/
HILtJ, A/J, C57BL/6J, 129S1/SvImJ, CAST/EiJ, PWK/PhJ, and WSB/EiJ). Here, we performed a comprehensive and 
comparative phenotyping screening to identify phenotypic differences and similarities between the eight founder strains. In 
total, more than 300 parameters including allergy, behavior, cardiovascular, clinical blood chemistry, dysmorphology, bone 
and cartilage, energy metabolism, eye and vision, immunology, lung function, neurology, nociception, and pathology were 
analyzed; in most traits from sixteen females and sixteen males. We identified over 270 parameters that were significantly 
different between strains. This study highlights the value of the founder and CC strains for phenotype-genotype associations 
of many genetic traits that are highly relevant to human diseases. All data described here are publicly available from the 
mouse phenome database for analyses and downloads.
Introduction
The mouse is the most extensively used mammalian model 
for biomedical research. Mouse genetic reference popula-
tions (GRPs) have become an important experimental sys-
tem to model the heterogeneity in the human population 
(Saul et al. 2019). Recently a new GRP, the Collaborative 
Cross (CC) was established (The Collaborative Cross Con-
sortium 2012). In contrast to classical recombinant inbred 
strains that use two strains as progenitors, eight inbred 
strains were used as parental strains. The eight founder 
strains represent the three major Mus musculus subspe-
cies: M. m. domesticus, M. m. musculus, and M. m. cas-
taneus. Five of the founder strains (A/J, C57BL/6J, 129S1/
SvImJ, NOD/ShiLtJ, NZO/HILtJ) are common laboratory 
strains, and three are wild-derived inbred strains (CAST/
EiJ, PWK/PhJ, and WSB/EiJ), each of which have different 
phenotypic characteristics. By combining eight founder 
strains, the genetic and phenotypic diversity is similar to 
that of the human population. As the genomic sequences of 
the eight founder strains are available (Keane et al. 2011; 
Lilue et al. 2018), the CC represents an unprecedented 
and unique resource for genetic mapping and correlation 
studies (Roberts et al. 2007). Detailed information about 
characteristics of the single founder strains can be found in 
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the Jackson laboratory (JAX) mice database (https ://www.
jax.org/jax-mice-and-servi ces).
In addition, there are numerous phenotyping data avail-
able for several founder strains that have been deposited in 
the Mouse Phenome Database (MPD; https ://pheno me.jax.
org; RRID:SCR_003212, (Bogue et al. 2018; Bogue et al. 
2019; Grubb et al. 2014). For example, a high-through-
put phenotyping protocol was used to measure the body 
composition and blood components of 43 inbred mouse 
strains including the CC founder strains after a high fat 
diet (Svenson et al. 2007). Furthermore, phenotype data 
are available for several focus areas e.g., immunology 
(Phillippi et al. 2014), morphology (Percival et al. 2016), 
behavior (Logan et al. 2013) and intestinal microbiota 
(Campbell et al. 2012). Also, founder strains were sub-
jected to multiple challenges such as susceptibility to 
quantum dot (Scoville et al. 2015), response to microbio-
logical (Smith et al. 2016) and viral (Ferris et al. 2013; 
Leist et al. 2016) infections. In this context, investigations 
of the pre-CC strains were often carried out as well (Fer-
ris et al. 2013; Gralinski et al. 2015; Kelada 2016; Kelada 
et al. 2012; Phillippi et al. 2014; Rutledge et al. 2014). 
However, a comprehensive and comparative phenotyping 
analysis that comprises many parameters in a single study 
has not yet been performed. Extensive phenotyping data 
from the parental strains will allow assessing which paren-
tal alleles may contribute to which part of the phenotypic 
spectrum and thus help to better interpret QTL studies 
(e.g., Ferris et al. 2013; Graham et al. 2015; Gralinski 
et al. 2013; Phillippi et al. 2014; Vered et al. 2014; Zhang 
et al. 2018).
Therefore, we carried out a large-scale phenotyping study 
at the German Mouse Clinic (GMC, www.mouse clini c.de) 
(Fuchs et al. 2011, 2009, 2012; Gailus-Durner et al. 2005). 
The GMC is one of 19 worldwide research institutions in 
the International Mouse Phenotyping Consortium [IMPC, 
(Dickinson et al. 2016)] to produce and phenotype mouse 
strains with the aim of characterizing a knockout mouse line 
for every protein-coding gene.
Here, the founder strains were examined in a phenotyping 
pipeline that comprises standardized procedures in the areas 
of behavior, bone and cartilage development, neurology, 
clinical chemistry, hematology, eye development, immunol-
ogy, allergy, energy metabolism, lung function, vision and 
pain perception, cardiology and pathology. Sixteen animals 
per sex and strain were examined in several batches to gen-
erate a statistically robust data set with the founder strains 
showing a high range of phenotypic differences. Our results 
confirmed already known strain characteristics and identi-
fied new phenotypes. Primary data and first line visualiza-
tion and analyses are publicly available in MPD and can be 
downloaded for further analyses.
Results
Outline of phenotyping strategy
We performed a comprehensive standardized phenotyping 
pipeline at the German Mouse Clinic (GMC) for all eight 
CC founder strains (A/J, C57BL/6J, 129S1/SvImJ, NOD/
ShiLtJ, NZO/HILtJ, CAST/EiJ, PWK/PhJ, and WSB/
EiJ) covering all clinically relevant physiological systems 
(Figs. 1, S1). Mice were bred by synchronized mating at 
the Helmholtz Centre for Infection Research with sixteen 
or more animals per sex and strain analyzed in a timeframe 
of one year (January 2013 to April 2014).
Furthermore, we used five cohorts in total, supplied 
every three months, and distributed mice from a given 
strain and sex over these cohorts to ensure the pheno-
typic characterization covered all seasons. Cohorts of 
age-matched (7 weeks old, plus/minus 7 days) mice from 
each strain were shipped to the animal facility of the 
Helmholtz Zentrum München. After 2 weeks of acclima-
tization, mice were subjected to a phenotyping pipeline 
that encompassed 303 parameters in many phenotypic 
domains: allergy, behavior, cardiovascular analysis, clini-
cal chemistry, hematology, dysmorphology including bone 
and cartilage, energy metabolism, eye analysis and vision, 
immunology, lung function, neurology, nociception, and 
pathology. In general, the same mice were tested for dif-
ferent phenotypes. In cases where mice did not survive the 
standardized workflow of 13 weeks, additional mice were 
used to achieve the targeted total number of 16 female 
and male mice per strain. Figure 1 summarizes the order 
and age of analysis for each procedure in the phenotyping 
pipeline. Fig. S1 details the order and the weeks of each 
measurement. The order of tests within the GMC pheno-
typing pipeline is based on experience from large-scale 
phenotyping efforts including the IMPC and EUMODIC 
programs. The order of tests reflects the input of experts 
from global research institutes about optimal age for each 
test and to minimize carry-over effects between tests 
including having sufficient recovery time between tests, 
e.g., having glucose challenge be the only test in a week 
period (Karp et al. 2015).
Phenotypic analyses were carried out in the German 
Mouse Clinic (GMC) at the Helmholtz Zentrum München 
by using standardized examination protocols (Fuchs 
et  al. 2011; Gailus-Durner et  al. 2009, 2005) (https ://
www.mouse clini c.de). The entire data set as well as the 
experimental procedures is available at MPD (https ://
pheno me.jax.org/). All derived data analyses described 
here (e.g. global analyses, regression analyses) were per-
formed with a data download from MPD dated 28.8.2018. 
The downloaded dataset (Data_dwnld_F1_20180828) 
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has been deposited at the public repository RADAR (see 
chapter Data availability) for reproducibility of the results 
described here. Please note that the current and future 
datasets at MPD might slightly diverge from a RADAR 
submission if errors have been corrected after that date or 
if data formats changed.
Deviations from the standard GMC phenotyping 
pipeline
In some cases, the GMC standard pipeline had to be modi-
fied to adapt to the special characteristics of some founder 
strains: For example, only a final bleeding was performed 
at week 21. Originally, blood sampling was also planned 
at week 17, but the wild-derived strains, WSB/EiJ, CAST/
EiJ and PWK/PhJ, were too small to collect blood at this 
time. In addition, wild-derived strains were highly sensitive 
to the ketamine/xylazine injection anesthesia. Therefore, 
data for eye screen, bone density analysis and ABR were not 
obtained for all strains. Since the wild-derived strains were 
small and light, it was not possible to perform the Glucose 
Tolerance Test (GTT) because fasting over night was not 
possible for these strains. NZO/HILtJ mice were too heavy 
to measure body mass and body composition by qNMR due 
to size limitation of the machine. Awake electrocardiogram 
and visual acuity measurements had to be omitted for WSB/
EiJ and CAST/EiJ since those strains were too active. The 
visual acuity measurement was not possible for NOD/ShiLtJ 
and A/J since these strains have an albino background. There 
are no rotarod data for WSB/EiJ since these mice were too 
active to stay on the apparatus. These limitations resulted in 
a reduction of the total number of mice per sex and strain for 
some parameters (Fig. 3 lists the total number of assays per 
GMC project per strain: significant parameters/total number 
of parameters measured per strain). However, most param-
eters were still measured with 16 animals per group. The 
exact number of mice for each parameter measurement can 
be found at MPD.
Besides these limitations, our phenotyping data represent 
the largest most comprehensive data set for the CC founder 
mice that will be highly valuable for the scientific commu-
nity providing a baseline for studies with CC strains and the 
Diversity Outbred (DO) resource as well as facilitating the 
identification of new models for human diseases.
Detailed phenotype data and first line analysis are 
publicly available in MPD
The phenotype data were deposited at MPD after extensive 
data quality control. In this step, extreme outliers caused 
by failures of machines or human error were excluded. In 
total, 303 parameters were uploaded to MPD. The data set is 
organized in 21 projects, each with a unique ID (GMC01 to 
GMC21) based on phenotypic domains. A procedure name 
describes a specific set of parameters, or measurements, in 
a given protocol (Fig. 1). The project protocol is attached in 
MPD and provides information about workflow, sampling, 
equipment, supplies, reagents, solutions and the type of data 
collected for each procedure. Each project has one acces-
sioned data set, which is available for download (https ://
Fig. 1  Overview of MPD projects, phenotypic domains and parameters measured
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pheno me.jax.org/). The downloadable tables contain the day 
of birth (DOB), date of test (DOT) and the values for each 
measured parameter including measurement units for each 
individual mouse and covariates like sex, body weight, etc.
For each measurement in MPD, a plot and overall sum-
mary table are provided as well as a table of strain means 
(unadjusted and Least Squares Means), standard deviation 
(SD), standard error of mean (SEM), number of mice, coef-
ficient of variation, and Z-scores. The means tables are 
searchable and sortable so that strains with special charac-
teristics may be quickly identified for each measurement. 
Individual animal data are available for online viewing or 
downloading. Analysis of variance (ANOVA) results are 
also made available such that sex, strain, and sex:strain 
interaction are analyzed. There is also a Q–Q normality 
assessment plot where theoretical quantile values are plotted 
against observed quantile values. Finally, for each eligible 
measurement, there is a possibility to run a genome-wide 
association analysis. Repeated measurements are plotted 
together so that trends in the data may be visualized. Each 
individual measurement of the repeated measurement series 
has the functionality just described. Some examples from the 
MPD data sets are shown and discussed below.
Global analysis of phenotype data reveals many 
significant differences between strains and sex
We performed two types of global analyses to determine 
statistically significant differences at the level of param-
eters. First, in MPD, an ANOVA was performed as part 
of the data upload and subsequent presentation in MPD 
(as detailed above) that describes statistically significant 
differences between groups, including covariates. Second, 
we performed a pairwise comparison, based on the IMPC 
statistical pipeline contrasting parameter measurements for 
each strain with C57BL/6J as reference (Kurbatova et al. 
2015). Both approaches are highly complementary. ANOVA 
provides a first level of statistical information for group dif-
ferences and relates to the data graphs shown in MPD. On 
the other hand, the IMPC statistical pipeline was especially 
developed to analyze large-scale data from mouse phenotyp-
ing pipelines and allows adjusting for several confounding 
factors. It reports the results from pairwise comparisons to 
the reference strain C57BL/6J.
For the ANOVA MPD analysis, 272 parameters were 
significantly different by strain and 132 parameters by sex; 
ANOVA of sex by strain interaction revealed 117 signifi-
cantly different parameters (Fig. 2, detailed results are pre-
sented in Tables S1, S2 and S3). Most different parameters 
between strains were found in the phenotypic domains ‘clini-
cal chemistry’, ‘open field’, ‘acoustic startle response, and 
‘prepulse inhibition’. A simple reason for this observation 
may be that these domains contained the largest number of 
parameters measured (compare to Fig. 2).
For the pairwise comparison based on the IMPC statis-
tical pipeline, a large number of strain-specific significant 
differences to the C57BL/6J reference can be found (Fig. 3) 
with A/J showing the largest number of significantly differ-
ent parameters and WSB/EiJ the least. However, it should be 
noted that these numbers are somewhat skewed by missing 
measurements in the wild-derived strains (Fig. 3; significant 
parameters/total number of parameters measured per strain).
A correlation heat map (Fig. 4, detailed results are shown 
in Table S4 and a high resolution figure is shown in Fig 
Fig. 2  Number of significant 
parameters per project by strain 
and sex after ANOVA. ANOVA 
results for all parameters were 
extracted from MPD (freeze 
from 28th August 2018) and 
summarized. p values for 
individual parameters were 
adjusted for multiple testing 
using BH correction separately 
for the fixed variables strain, sex 
and sex:strain interaction. The 
figure illustrates the number of 
significant (p < 0.05) param-
eter measurements for each 
MPD project for the indicated 
explanatory variables
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S3) for all parameter measurements showed that the largest 
number of procedures were measured for GMC01 (behavior, 
open field) and that all results from this trait were highly 
correlated. In addition, several correlations existed between 
various MPD projects, e.g., GMC01 (behavior, open field) 
and GMC09 (metabolism, calorimetry) suggesting that 
activity in mice was correlated with energy metabolism. 
Also, GMC21 (organ weights) was correlated with several 
other GMC projects, notably GMC10 (metabolism, NMR), 
GMC11 (clinical chemistry, IGTT) indicating correlations 
between metabolic and clinical chemistry traits.
The CC parental strains consist of three laboratory strains 
(A/J, C57BL/6J, 129S1/SvImJ), two disease models (NOD/
ShiLtJ, NZO/HILtJ) and three wild-derived (CAST/EiJ, 
PWK/PhJ, and WSB/EiJ) strains. We performed an ANOVA 
to identify significant differences between these groups 
(Table S5). 144 parameter measurements were significantly 
different (p < 0.05) between the laboratory and wild-derived 
strains (top three most abundant procedures: Open_field: 
32; Acoustic_Startle: 18; Dual_Energy_Xray_Absorptiom-
etry: 13) and 163 parameters were significantly different 
(p < 0.05) between the laboratory strains and the disease 
models (top three most abundant procedures: Open_field: 
25; SHIRPA: 13; Eye_size: 11). To illustrate further the dif-
ferences between strains for any given parameter, we gener-
ated heat maps for each project using the means for each 
measurement per strain (examples are shown in Fig. 5 and 
all results are presented in Fig. S2). In general, there was 
no consistent pattern over all strains, e.g., that wild-derived 
strains would always differ from the other strains. Group-
ings were specific for each project. For example, for GMC01 
(Open field; Fig. 5a), the difference in behavior (high rest-
ing time in center) between the diabetic strain NOD/ShiLtJ, 
the obese strain NZO/HILtJ (low resting time in center) 
and all others was quite obvious. Low grip strength values 
(all_paws_adj) for NOD/ShiLtJ in GMC02 was one of the 
strongest differences to all other strains (Fig. 5b) whereas 
it was high for all wild-derived trains. All wild-derived 
strains were low for GMC18 (Xray absorptiometry, Fig. 5c) 
whereas NZO/HILtJ was high, indicating a difference in 
Fig. 3  Number of significant 
parameters after pairwise com-
parisons of individual strains 
to C57BL/6J. Overview of the 
pairwise comparison of each 
founder strain to C57BL/6J as 
the reference. p values obtained 
from each individual compari-
son of parameters were adjusted 
for multiple testing using BH 
correction. The Figure summa-
rizes the number of significant 
(p < 0.05) parameter measure-
ments per MPD project from 
each pairwise comparison of the 
indicated strain to C57BL/6J 
per total number of assays 
performed
Fig. 4  Correlation map of MPD projects. Pearson correlations 
between numerical values from all procedure measurements were cal-
culated and then represented as heat map. A high resolution heat map 
with labels for all procedures can be found in the supplemental mate-
rial (Fig. S3)
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body composition between wild-derived and laboratory 
strains and an outsider position for NZO/HILtJ.
Mice were shipped in five cohorts (batches). We thus per-
formed an ANOVA for all measured parameters and batch as 
explanatory variable (model: parameter ~ batch) to evaluate 
possible batch effects. The results are listed in Table S6; 80 
measurements showed significant batch effects (p < 0.01). 
Thus, batch was included in the model for the pairwise 
Fig. 5  Heat maps of measurements for individual GMC projects. Heat maps of the means per strain for a given GMC project are shown. a 
GMC01, b GMC02, c GMC18. Values were scaled by rows (parameter measurements). Blue: low values, red: high values
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comparisons, and we corrected for this effect for the above 
analyses.
Ethics committees frequently request a power analysis to 
determine group sizes for approval of animal experimental 
protocols. However, this is often impossible because no data 
exist or are not available as raw data from publications. Our 
extensive data set on the phenotypes from the CC founder 
will allow performing power calculations for many pheno-
typic traits because the raw data are readily accessible at 
MPD, group sizes in our settings are large enough to per-
form a power analysis, the appropriate comparison and delta 
of means can be selected. As an example, we performed 
a power analyses for three significant phenotype measure-
ments based on pairwise comparisons from projects GMC01 
and GMC16. Group sizes for power were calculated using 
the following settings: power = 0.8, significance level = 0.05, 
standard deviation (sd) = mean of all sd values for the 
selected parameter over all strains, delta = difference in 
means between strains. The results are listed in Table S7. It 
becomes evident that group sizes are highly variable depend-
ing on which strains to compare and the selected difference 
in means. Thus, our data should provide a valuable resource 
to decide for the appropriate comparisons and group sizes.
Examples of phenotypes from the pipeline analyses
Below, we describe some selected projects/phenotypes in 
more detail to give the reader some insights into the type of 
results that we obtained, as well as differences that can be 
observed between groups, and the discovery of novel phe-
notypes and the data visualizations and analysis tools that 
are provided in MPD.
Spontaneous locomotor activity
Open Field tests are widely used as assay to measure spon-
taneous locomotor and exploratory activity as well as anxi-
ety in a novel environment. Figure 6 illustrates the data 
representation that can be found in MPD for the parameter 
measurements from this project (GMC01): ‘distance trave-
led total, 20 min test’ (Fig. 6a), ‘rearing activity, number of 
rears total, 20 min test’ (Fig. 6b), and ‘percentage of total 
time spent in the center, 20 min test’ (Fig. 6c). We found that 
spontaneous locomotor activity measured in the Open Field 
test was highest in NOD/ShiLtJ, followed by C57BL/6J, and 
lowest in A/J and NZO/HILtJ mice. The other strains were 
intermediate; from most to least active: WSB/EiJ, CAST/
EiJ, PWK/PhJ and 129S1/SvImJ (Fig. 6a). With respect to 
rearing activity in the open field (Fig. 6b) A/J and 129S1/
SvImJ were engaging the least while NOD/ShiLtJ, PWK/
PhJ, CAST/EiJ and C57BL/6J mice were rearing at compa-
rable frequencies. With respect to anxiety-related behavior 
measured by center time (%) in the central, aversive zone of 
the Open Field (Fig. 6c), A/J and 129S1/SvImJ mice spent 
the least time in the center, while NOD/ShiLtJ spent the 
most time in the center.
Acoustic startle reactivity and its prepulse inhibition
Prepulse inhibition of the acoustic startle reflex is a reli-
able measure of sensorimotor gating that is highly con-
served across species. Dysfunctions in prepulse inhibition 
are prominent in several neurodevelopmental psychiatric 
disorders, e.g., schizophrenia amongst others. As shown 
in Figs. 7a and b, NZO/HILtJ mice demonstrated the high-
est startle response relative to all other strains (GMC05). 
NOD/ShiLtJ, WSB/EiJ, CAST/EiJ, PWK/PhJ and A/J 
mice showed comparably low responses, while C57BL/6J 
and 129S1/SvImJ mice had intermediate values. The high-
est prepulse inhibition responses were observed in 129S1/
SvImJ, with C57BL/6J mice ranking the second highest, and 
A/J mice showing the lowest PPI levels (Fig. 7c). The other 
mouse strains had intermediate values and within a broadly 
similar range.
Hearing sensitivity
Hearing loss is a common condition in humans that can be 
caused by many environmental and genetic factors. Here, 
we measured auditory brainstem response (ABR) to evalu-
ate hearing sensitivity in the eight founder strains. ABR 
was performed by applying different sound stimuli (one 
broadband click and five pure tones) to anesthetized mice 
and determination of the critical sound pressure threshold 
needed for ABR response was determined. The differences 
in startle responses in the project GMC05 “acoustic startle 
reactivity and its pre-pulse inhibition” were reflected by the 
hearing sensitivity of the different strains: A/J and NOD/
ShiLtJ showing low startle response seemed to be nearly 
insensitive for all ABR frequencies tested. However, some 
of the NZO/HILtJ mice were nearly deaf, while others were 
still within physiological ranges when measuring auditory 
brainstem response to a click stimulus (Fig. 7d).
Grip strength
Grip strength maybe affected by muscle function itself, the 
neuromuscular control of the muscle as well as by energy 
metabolism parameters. To assess muscle function, grip 
strength was measured (GMC02). Grip strength was high-
est in NOD/ShiLtJ and lowest in CAST/EiJ mice (Fig. 8a). 
On the other hand, NOD/ShiLtJ mice had also high body 
weight (after NZO/HILtJ) whereas CAST/EiJ had lowest 
body weight (ratio grip strength and body weight indicated 
in Fig. 8b). Including body weight as a covariate revealed a 
statistically significant correlation for grip strength and body 
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Fig. 6  MPD view of project GMC01. a GMC01—distance traveled 
total, 20 min test; b GMC01—number of rears total, 20 min test; c 
GMC01—resting time in center of arena, 20 min test. Each dot rep-
resents the value for a single mouse, males in blue, females in red. 
Solid vertical bars show the means and standard error of mean (SEM) 
for each strain (red for females, blue for males). Stippled lines indi-
cate the overall mean per sex and standard deviation (SD). x-axis: 
strain names; y-axis a distance traveled in cm (cm); y-axis b total 
number of rears (n); y-axis c percent of total time spent in center (%); 
The detailed protocols can be found in MPD
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Fig. 7  MPD view of project GMC05. GMC05—acoustic startle 
response MPD:55,411 ASR  acoustic startle response (ASR)[ampli-
tude] a females, b males; c GMC05—percentage prepulse inhibition 
(PPI) evoked by 110  dB sound pressure level with global prepulse 
stimulus; d GMC17—auditory brainstem response (ABR) thresh-
old, sound pressure level, click stimulus. Note that PWK/PhJ was not 
measured for ABR due to anesthesia intolerance. Each dot represents 
the value for a single mouse, males in blue, females in red. Solid 
vertical bars show the means and standard error of mean (SEM) for 
each strain (red for females, blue for males). Stippled lines indicate 
the overall mean per sex and standard deviation (SD). x-axis: strain 
names; y-axis a amplitude measured (db, decibel); y-axis b ampli-
tude measured (db); y-axis c percent (%); y-axis d decibel (db) The 
detailed protocols can be found in MPD
Fig. 8  MPD view of project GMC02. a GMC02—forelimb grip 
strength, mean; b GMC02—forelimb and hindlimb grip strength 
(mean) divided by body weight; c Correlation of mean grip strength 
of all paws pooled for both sexes to body weight (black line for all 
strains except NZO/HILtJ), NZO/HILtJ: blue symbols and line. Each 
dot represents the value for a single mouse, males in blue, females in 
red. Solid vertical bars show the means and standard error of mean 
(SEM) for each strain (red for females, blue for males). Stippled lines 
indicate the overall mean per sex and standard deviation (SD). x-axis 
in a and b: strain names; y-axis a grip strength force meter in gram 
(g); y-axis b ratio of grip strength to body weight (ratio); x-axis in c 
body weight in gram (g); y-axis c grip strength force meter in gram 
(g); The detailed protocols can be found in MPD
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weight, as shown in Fig. 8c. NZO/HILtJ clustered differ-
ently indicating that they were weak given their body weight 
(Fig. 8c) since these mice have a large amount of body fat 
and a lean mass more similar to NOD/ShiLtJ mice (data not 
shown). On the other hand, NZO/HILtJ mice develop obe-
sity and glucose intolerance and therefore muscle function 
could be impaired directly as well. Often, mutant mouse 
lines show differences in body weight (Reed et al. 2008) 
and these differences might correlate with other parameters 
as well like bone mineral density or lean mass (Karp et al. 
2012; Oellrich et al. 2016). Muscle strength had not been 
reported yet for NZO/HILtJ mice but it had been shown that 
endurance as well as activity was reduced in NZO/HILtJ 
mice (Courtney and Massett 2012).
Neurological analysis
For basic neurobehavioral assessment and an overall vis-
ual inspection a SHIRPA [SmithKline Beecham, Harwell, 
Imperial College, Royal London Hospital, phenotype assess-
ment (Rogers et al. 2001)] protocol was used in a modified 
form for rating observations for abnormalities of general 
appearance, movement and some reflexes (GMC03, data not 
shown). Differences were detected between several strains: 
less tail elevation in NZO/HILtJ and A/J, differences in pel-
vic elevation (less in NZO/HILtJ, PWK/PhJ, A/J and 129S1/
SvImJ), less startle response in A/J (see hearing sensitivity 
results), less transfer arousal in A/J and NZO/HILtJ. Loco-
motor activity was reduced in NZO/HILtJ, A/J, 129S1/SvImJ 
and PWK/PhJ mice compared to C57BL/6J (A/J < NZO/
HILtJ < 129S1/SvImJ < PWK/PhJ < WSB/EiJ < CAST/
EiJ < C57BL/6J < NOD/ShiLtJ, data not shown).
Eye analysis
The visual capability of a mouse may influence many other 
traits. Therefore, it is important to consider also eye mor-
phology and visual capability. In order to identify differ-
ences in eye size, morphology of the anterior and posterior 
segment of the eye, as well as visual acuity between the 
strains, the animals were tested in the virtual drum after 
that examined with the Scheimpflug rotating camera, laser 
interference biometry (LIB) and optical coherence tomogra-
phy (OCT; GMC14, data not shown). The eye screen identi-
fied subtle differences between the strains (data not shown). 
Specifically, Scheimpflug imaging for the anterior eye seg-
ment showed higher lens density for the A/J mice, followed 
by the NOD/ShiLtJ and 129S1/SvImJ animals whereas the 
WSB/EiJ, C57BL/6J, CAST/EiJ and NZO/HILtJ showed 
almost comparable lens density. The posterior part of the 
eyeball (fundus), was visualized by the means of OCT. OCT 
examination revealed normally developed retinal layers in all 
mouse strains. The number of the retinal main blood vessels 
was comparable between all strains. The strains with the 
highest retinal thickness were the C57BL/6J, A/J and 129S1/
SvImJ, followed by the PWK/PhJ, NZO/HILtJ, CAST/EiJ 
and WSB/EiJ strains that have comparable retinal thick-
nesses. Analysis of the size of the ocular components by 
LIB, in the CC strains, indicated a variable strain depend-
ent eye axial size, suggesting a significant role of genetic 
background in eye development. For example, the NOD/
ShiLtJ mice had the longest eye axial length, followed by 
NZO/HILtJ mice. The other mouse strains presented com-
parative eye sizes: C57BL/6J > A/J > 129S1/SvImJ > WSB/
EiJ > PWK/PhJ > CAST/EiJ. Visual acuity testing was not 
performed in all mouse strains e.g., due to hyperactivity 
observed for PWK/PhJ, CAST/EiJ, and WSB/EiJ. In addi-
tion, the NOD/ShiLtJ and A/J strains were not tested in the 
virtual drum because of the albino background, known to be 
characterized by reduced visual acuity due to melanin syn-
thesis disorders that predisposes the visual system to abnor-
malities affecting the retina and the retinofugal projections. 
Of the drum-tested strains, C57BL/6J mice showed weaker 
visual acuity compared to the NZO/HILtJ and 129S1/SvImJ 
mice. 129S1/SvImJ mice were found to have a comparable 
visual acuity to C57BL/6J mice (Wong and Brown 2006).
Clinical chemistry
An assessment of blood chemistry parameters provides a 
good overview of the metabolic state, organ functions as 
well as electrolyte and mineral homeostasis. The studies 
can provide hints towards genetically determined disease 
susceptibilities. Plasma clinical chemistry had been meas-
ured for the Collaborative Cross founder strains before in 
two studies published in the Mouse Phenome Database 
(CGDpheno3, Chesler2). Our studies confirm many of the 
findings from these studies (GMC16). For example, we also 
found extremely high cholesterol levels in NZO/HILtJ, and 
compared to C57BL/6J elevated levels in 129S1/SvImJ 
and WSB/EiJ animals, while PWK/PhJ, A/J and CAST/EiJ 
showed lower levels. Similarly, already published strain-
related differences in glucose, triglyceride, calcium and 
urea levels were mostly confirmed. However, the param-
eters presented in these two studies do not include phos-
phate values, enzyme activities or parameters related to iron 
metabolism. For these parameters comparative data from 
literature are rare. One of the most striking results was our 
findings concerning parameters of mineral metabolism in 
A/J mice. Compared to all other strains, A/J mice exhibited 
slightly elevated sodium levels and significant hyperpho-
shatemia, while no strong deviations from the other strains 
were observed for potassium levels (Fig. 9a, b, c). A/J mice 
also differed from other strains by showing an inverted sex 
difference for alkaline phosphatase activity in this strain with 
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higher values in males than in females, while for all other 
strains there was no difference or inverse relationships.
Glucose tolerance test
Diabetes is a common metabolic disorder in humans. Dif-
ferent types of monogenic or complex genesis can be dif-
ferentiated. The glucose tolerance test is the standard mean 
to identify diabetes or pre-diabetic states in men and mice. 
In addition, subtle differences in the regulation of glucose 
metabolism, possibly affecting general metabolic state, the 
response to diet challenges and susceptibility to age-related 
diseases, can be detected by this test in mice. Intraperito-
neal glucose tolerance tests were performed at the age of 
13–14 weeks. The results confirmed several well-known 
strain-specific characteristics, such as impaired glucose 
tolerance in NZO/HILtJ and NOD/ShiLtJ mice (Chen et al. 
2018; Kleinert et al. 2018) and references therein) (GMC11, 
data not shown). In contrast, 129S1/SvImJ mice showed 
very low basal fasting glucose levels and low AUC values, 
which is in line with the observation of low endogenous 
glucose production in fasting 129S1/SvImJ mice (Bur-
gess et al. 2005). Due to low body mass in wild-derived 
strains, only male animals of the PWK/PhJ strain could 
Fig. 9  MPD view of project 
GMC16. a GMC16—sodium 
(plasma Na) at age 20–21 
weeks; b GMC16—potassium 
(plasma K) at age 20–21 weeks; 
c GMC16—phosphorus (plasma 
phosphate) at age 20–21 weeks. 
Each dot represents the value 
for a single mouse, males in 
blue, females in red. Solid verti-
cal bars show the means and 
standard error of mean (SEM) 
for each strain (red for females, 
blue for males). Stippled lines 
indicate the overall mean per 
sex and standard deviation 
(SD). x-axis: strain names; 
y-axis a plasma Na at age 
20–21 weeks in mMol per liter 
(mmol/L); y-axis b plasma K at 
age 20–21 weeks in mMol per 
liter (mmol/L); y-axis c plasma 
phosphate at age 20–21 weeks 
in mMol per liter (mmol/L); 
The detailed protocols can be 
found in MPD
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be tested for glucose tolerance. These animals showed a 
similar phenotype as C57BL/6J mice. For NZO/HILtJ, lean 
and fat measurement data have been deposited previously 
in MPD (Multi-system survey of mouse physiology in 72 
inbred strains of mice MPD:CGDpheno1; Mouse Phenome 
Database web resource; RRID:SCR_003212; https ://pheno 
me.jax.org), indicating a high body fat proportion. This is 
important to consider, since body composition besides other 
factors also affects the outcome of glucose tolerance tests 
(Jorgensen et al. 2017).
Pathology screen and heart weight
Light microscopy histological analysis of 30 examined 
organs did not reveal new strain-specific changes. Hearts of 
female and male NZO/HILtJ mice appeared hypertrophic 
when compared to the hearts of the other mouse strains 
(Fig. 10) but NZO/HILtJ were also bigger and heavier. 
Therefore, understanding the influence of covariates was of 
special interest.
The analysis of heart weight represents an ideal example 
to illustrate how data from MPD can be further explored to 
obtain more insights into strain differences and the influ-
ence of covariates. Project GMC21 measured heart weight 
together with several covariates, sex, body weight and tibia 
length. Heart weight/tibia lengths ratio is a parameter often 
used for investigation of cardiac hypertrophy. The optimized 
ANOVA model (see M&M) showed that all three parameters 
(strain, sex and body weight) were significant (Table S8). 
Also, wild-derived strains were significantly different from 
the laboratory strains and each of the disease models was 
different from all other strains. These findings are illus-
trated in Fig. 11 where heart weight was corrected for body 
weight. The wild-derived strains exhibited significantly 
higher heart weights (p < 0.001) compared to the classical 
laboratory strains (Fig. 11). Also, the disease model strains 
NOD/ShiLtJ and NZO/HILtJ differed (individually) from 
all other strains (p < 0.001) with NZO/HILtJ females show-
ing a decrease in heart weight/body ratio. In summary, this 
example demonstrates how raw data from MPD can be used 
by special interest groups for further analysis of strain differ-
ences and variables that control such differences.
Discussion
Here, we present the first comprehensive phenotyping analy-
sis of the CC founder strains using a standardized phenotyp-
ing pipeline. Three hundred and three (303) parameters were 
measured for all eight CC founder strains over a period of 
15 months. We aimed for large group sizes (most param-
eters were measured for 16 animals for all strains and both 
sexes). This allowed us to obtain statistically robust results 
that include contrasting groups of strains, single strains to 
all others, effects of sex and other covariates.
All primary data can be accessed and downloaded from 
the public MPD database. It thus provides a highly valuable 
public resource for physiological, morphological and behav-
ioral phenotype data of the CC founder and will serve as an 
important reference for baseline values to better understand 
phenotypes in the recombinant inbred CC strain collection 
(The Collaborative Cross Consortium 2012), the outbred 
Diversity Outcross resource (DO, (Churchill et al. 2012; 
Svenson et al. 2012), F1 mice generated from CC strains, 
and future resources that will be generated from the CC 
founder strains.
MPD also provides online visualization and a first line 
statistical analysis of the data allowing an easily accessi-
ble overview for each phenotypic measurement also for less 
experienced users or less sophisticated analyses. In addition, 
the raw data sets can be directly downloaded from the MPD 
database for further detailed analyses of individual traits, 
correlation studies between traits and groups or comparisons 
to other data sets.
Our study corroborates and extends phenotypic character-
istics of the CC founder strains that were described before, 
like spontaneous locomotor activities, motor skills and grip 
strength. In addition, several differences between strains and 
sexes have not been reported before, like deafness of NZO/
HILtJ mice and heart to body weight ratios between labora-
tory and wild-derived strains. Below, we discuss some of 
our findings without trying to be comprehensive but rather 
to demonstrate for a few examples the value of the data as 
resource for the scientific community.
The largest set of phenotypes was obtained for behavioral 
and neurological parameters. In our spontaneous locomotor 
activity analysis, the NOD/ShiLtJ was the most active, and 
A/J and NZO/HILtJ were the least active. These results are 
generally consistent with previously published open field 
analyses of the CC founder strains (Amrani et al. 1994; Lad 
et al. 2010; Logan et al. 2013; Takahashi et al. 2006), and a 
similar pattern of A/J < 129S1/SvImJ < C57BL/6J in terms 
of locomotor activity has also been observed elsewhere 
(Bohlen et al. 2014; Mandillo et al. 2008). Similarly, the 
strain ranking of anxiety-related behavior is in line with pre-
vious reports (Lad et al. 2010), e.g., it was shown that, and 
also consistently across different testing centers, C57BL/6J 
mice spend more time in the center of the open field than 
129S1/SvImJ mice (Kulesskaya and Voikar 2014; Mandillo 
et al. 2008).
Differences in startle responses may be due to differ-
ences in hearing sensitivity, neuromuscular recruitment 
or anxiety-related behavior. In NZO/HILtJ mice, how-
ever, the measurement of ABR showed that some of the 
NZO/HILtJ mice were nearly deaf while others were 
still hearing well. The high startle response was possibly 
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confounded by their higher body weight, since startle 
amplitudes reflect alterations in the weight placed on the 
highly sensitive measuring platform, and are thus influ-
enced by body weight. While the body weight normalized 
analysis of this response brought the levels of NZO/HILtJ 
mice closer to the other lines, they still did not exhibit 
the low startle measurement that would be characteris-
tic of a hearing impairment. This suggests that in this 
line, hearing loss manifested during the 7 weeks between 
ASR and ABR measurement, potentially enhanced by the 
Fig. 10  Histological sections of hearts from CC founder strains. His-
tological sections show the left (LV) and right (RV) ventricular free 
walls, the left and right auricles and part of the aorta root. The upper 
two rows display heart histology of male mice, the lower two rows 
histology of female mice. Note the differences in thickening of the LV 
myocardium between NZO/HILtJ (7  mm) and CAST/EiJ (4.5  mm) 
strains (black arrows)
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noise exposure during the ASR test. Several inbred mouse 
strains exhibited a progressive, non-syndromic hearing 
loss with variable onset (Zheng et al. 1999), but a gen-
eral hearing impairment has not been described before in 
NZO/HILt mice. Interestingly, these mice carry a mutation 
inactivating PCTP (Phosphatidylcholine transfer protein) 
(Pan et al. 2006) which is downregulated in auditory glia 
cells in response to loud noise exposure (Panganiban et al. 
2018). Recent literature suggests a link for diabetes and 
hearing loss in men and mice (Akinpelu et al. 2014; Hong 
and Kang 2014; Horikawa et al. 2013) but we did not test 
for a correlation of pre-diabetic stages and hearing loss of 
NZO/HILtJ mice. The NOD/ShiLtJ and A/J mouse strains 
were deemed to be deaf as tested by ABR as described 
before for A/J and another sub-strain of NOD (NOD/LtJ 
(Johnson et al. 2006). Thus, the pattern of lower ASR in 
these mice was consistent with this finding. The WSB/EiJ, 
PWK/PhJ and CAST/EiJ mice also showed relatively low 
ASR. The pattern of higher ASR in the 129S1/SvImJ strain 
relative to the C57BL/6J strain (that undergoes progres-
sive sensorineural hearing loss) has been described before 
(Johnson et al. 2006; Mandillo et al. 2008; Zheng et al. 
1999). Hearing sensitivity was high for the wild-derived 
strains PWK/PhJ, WSB/EiJ and CAST/EiJ thus confirming 
current literature (Johnson et al. 2006).
Motor skills as evident from the rotarod performance 
were quite similar, but lowest in A/J mice and 129S1/
SvImJ mice. This was also described before by Bohlen 
et al. (Bohlen et al. 2014). WSB/EiJ mice could not be 
measured at the accelerating rotarod since they were not 
cooperative and jumped immediately from the rod.
Plasma clinical chemistry had been measured for the 
Collaborative Cross founder strains before in two studies 
published on the Mouse Phenome Database (CGDpheno3, 
Chesler2), and our data confirm many of the findings of 
these studies, e.g., elevated cholesterol levels in NZO/
HILtJ and 129S1/SvImJ mice in contrast to CAST/EiJ 
mice with low values (O’Connor et al. 2014). The same 
was true for several other parameters measured. For exam-
ple glucose, triglycerides, creatinine, urea and electrolytes, 
that were also included in one of the studies published 
on MPD. There are only few previous publications com-
paring a broad range of clinical chemistry parameters for 
mouse-inbred strains, for example (Champy et al. 2008) 
comparing C57BL/6J, C3HeB/FeJ, BALB/cByJ and 129/
SvPas mice. These studies included only a fraction of the 
strains tested in our study, and often even not the same 
sub-strains, which makes the comparison of results dif-
ficult. However, the mentioned study still reports similar 
results concerning the differences between C57BL/6J and 
the 129/SvPas strain as we found in our study. For exam-
ple, it also described lower plasma phosphorus values than 
seen in C57BL/6J for the 129 strain. A/J mice exhibited 
slightly elevated sodium levels and significant hyper-
phoshatemia. There are no reports in the literature for 
plasma phosphorus levels in A/J mice. Another study in 
MPD (Yuan3: Aging study: Blood chemistry for 32 inbred 
strains of mice) compared 28 inbred strains including A/J 
for clinical blood chemistry at 6, 12 and 18 months of age. 
It is the only study in the MPD database including values 
of serum phosphorus measurements, and shows compara-
bly high values for 6 months old male A/J mice, but not for 
females. Therefore, this study is the first one showing such 
a clear shift in plasma phosphate levels for A/J mice. The 
observation that plasma mineral levels in A/J mice differ 
from those measured in C57BL/6J animals, is interesting 
in the context of a recent study showing remarkable dif-
ferences in bone structure between these strains (Mathis 
et al., 2019), since both observations point towards strong 
strain-related effects on the regulation of mineral and bone 
metabolism.
In summary, with our studies we provide a highly valu-
able public resource for the scientific community working 
with genetic reference populations that are derived from 
the Collaborative Cross founder mice such as CC strains, 
F1 and F2 populations as well as the DO (diversity out-
bred) mice. Our resource reports baseline values for the 
eight CC founder strains, obtained by standardized phe-
notype assays at the German Mouse Clinics. These data 
will represent an important reference for other phenotype 
analysis in CC founders and their derived populations.
Fig. 11  Correlation of heart to body weight for project GMC21. Data 
for GMC21 were downloaded from MPD (freeze from 28th August 
2018). The histogram illustrates heart to body weight ratios for male 
(_m) and female (_f) mice from each strain. Box plot centerline: 
median, box plot limits: upper and lower quartiles, box plot whiskers: 
1.5 × interquartile range
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Materials and methods
Ethics statement
Housing and handling of mice was according to the German 
Animal Welfare Act. All animal experiments were approved 
by the authority of the Regierung von Oberbayern.
Mice
The CC founder strains (A/J, C57BL/6J, 129S1/SvImJ, 
NOD/ShiLtJ, NZO/HILtJ, CAST/EiJ, PWK/PhJ, WSB/EiJ) 
were purchased from The Jackson Laboratory (Bar Harbor, 
ME) and bred in our animal facility at the Helmholtz Cen-
tre, Braunschweig for two to six generations depending on 
the strain. All mice were maintained under specific patho-
gen free conditions and according to the German animal 
welfare law. At the HZI, mice were housed in IVC cages 
(Techniplast Sealsafe, Typ 1284L) and paper tissues as cage 
enrichments with a light–dark cycle of 14 h/10 h without 
changes to summer savings time. Mice were fed standard 
diet (Ssniff V1534-300). At the GMC mice were housed in 
individually ventilated caging (IVC) systems (IVC System 
Green Line, Tecniplast, Italy), with a 12/12 h light–dark 
cycle, and red houses as cage enrichment. The IVCs operate 
at positive pressure. Mice were fed with irradiated standard 
and breeding rodent diet (Altromin 1314) ad libitum unless 
indicated otherwise. At 7 weeks of age, up to five cohorts 
with about four animals per sex and strain were shipped to 
the Helmholtz Zentrum Munich. Mice were acclimatized for 
2 weeks before testing started at 9 weeks of age.
Phenotyping analysis
The phenotyping assays are described in detail for each pro-
ject in the MPD database (https ://pheno me.jax.org/).
Statistical analysis
For ANOVA, the standard first line analysis in MPD was 
used (see descriptions in MPD). It used a model that incor-
porated a combination of fixed factors: sex, strain, and/or 
label. Label refers to a fixed factor with at least two lev-
els (for example when measurements were taken at differ-
ent times, e.g., for GMC01, distance traveled, successive 
5 min intervals). If more than one fixed factor was present, 
the interaction term(s) were included in the model. Data 
were not transformed and were analyzed with the assump-
tion that model residuals were normally distributed. When 
the label term referred to a repeated measure, a repeated 
measures ANOVA was used with the same fixed factor setup 
and subjects set as a random model factor. Repeated meas-
ures data were assumed to meet the sphericity criteria. For 
a global overview, we extracted the ANOVA results for all 
parameters from MPD (freeze from dated 28.8.2018) and 
summarized them as follows: p values for individual param-
eters were adjusted for multiple testing using BH correction 
(Benjamini and Hochberg 1995)—separately for the fixed 
variables strain, sex and sex:strain interaction.
Second, a pairwise comparison was performed which was 
based on the IMPC statistical pipeline contrasting parameter 
measurements for each strain with C57BL/6J as reference 
(Kurbatova et al. 2015). Data were downloaded from MPD 
(version from 28th August 2018) and inspected for quality 
control measures such as missing, mislabeled values and/or 
dates etc. which were then corrected. An optimized Linear 
Mixed model (West et al. 2014) with Batch in the random 
effect were applied to the data, so that the C57B6/J was 
considered as the baseline group to compare with the other 
strains. The term “optimized” refers to a backward elimina-
tion approach to remove the terms that are not significant (at 
the level of 0.05) in the saturated model below:
The analysis complies with the IMPC statistical pipeline 
and the implementation in the R package PhenStat (Kur-
batova et al. 2015). The outcome of the statistical pipeline 
was then assigned a mammalian phenotype (MP) term using 
a modified version of the IMPC algorithm. The detailed 
results were deposited at the public repository RADAR (link 
see below). For a global overview, the results of the pairwise 
comparisons between strains (males and females combined) 
were then summarized as follows: p values from individual 
comparisons of parameters were adjusted for multiple test-
ing using BH correction (Benjamini and Hochberg 1995). 
Summarization of ANOVA and pairwise comparison results 
were performed in R (version 3.4.0).
For the detailed analysis of the heart phenotype (project 
GMC21), we downloaded the raw data from MPD (freeze 
from 28th August 2018) comprising a total of 179 data 
points for 10–12 females and 12 males per strain. Log-trans-
formation of the response variable (heart weight) yielded a 
normal distribution. We then used a linear regression model 
to describe the response variable (heart weight), starting 
with a model that only contained strain as the fixed variable 
since this variable was the focus of our study. Strain showed 
a strong significant effect. When sex was added to the model, 
its significance increased. The interaction strain*sex did not 
(1)Response (parameter) = strain + sex + strain × sex interaction + body weight + batch (random effect).
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have a significant effect. Also, tibia length did not have a sig-
nificant effect nor improve the model. However, body weight 
had a significant effect and further improved the model. The 
final model which best explained the data was the following: 
lm(log(heart_wt) ~ strain + sex + body weight. The model 
was then tested for normality, and eight data points were 
removed as outliers in two iterative steps to improve normal-
ity. This model was then used to determine strain contrasts.
Data availability
The datasets generated or analyzed during the current study 
are available at the following public repositories. All pri-
mary data generated from this phenotyping project are 
available in 21 MPD projects (GMC01 to GMC21) at MPD 
(https ://pheno me.jax.org/). The raw data for each project 
are available for download at MPD (https ://pheno me.jax.
org/). Additional datasets (download from MPD used for 
the analyses described in this manuscript, results from pair-
wise comparison of each strain with C57BL/6J as reference) 
were deposited at the public repository RADAR (https ://
www.radar -servi ce.eu/radar /en/datas et/ItEsC rKZDK oHnjf 
W?token =aHyoE KSXTF POnSO FQXXe ).
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